The DOI matches its Crossref record.
Molecular cloning and expression of an IL-6 signal transducer, gp130
Abstract
Interleukin-6 (IL-6) signal is transduced through a membrane glycoprotein, gp130, which associates with IL-6 receptor (IL-6-R). A cDNA encoding human gp130 has been cloned, revealing that it consists of 918 amino acids with a single transmembrane domain. The extracellular region comprises six units of a fibronectin type III module, and part of this region of approximately 200 amino acids has features typical of a cytokine receptor family. A cDNA-expressed gp130 showed no binding property to IL-6 or several other cytokines. Although a transfectant with an IL-6-R cDNA expressed mainly low affinity IL-6 binding sites, an increase in high affinity binding sites was observed after cotransfection with a gp130 cDNA. This confirmed that a gp130 is involved in the formation of high affinity IL-6 binding sites. A cloned gp130 could associate with a complex of IL-6 and soluble IL-6-R and transduce the growth signal when expressed in a murine IL-3-dependent cell line.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IL-6R exists in an 80 kDa transmembrane form and a 50-55 kDa soluble form (sIL-6R).
“Unlike gp130, IL-6R exists in an 80 kDa transmembrane form and a 50–55 kDa soluble form (sIL-6R) (Hibi et al., 1990”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as Hibi et al., 1990
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 47
- Akira, 1990, A nuclear factor for IL-6 expression (NF-IL6) is a member of a CEBP family, EMBO J., 9, 1897, 10.1002/j.1460-2075.1990.tb08316.x · DOI
- Andus, 1987, Recombinant human B cell stimulatory factor 2 (BSF-2IFNβ2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells, FEBS Lett., 221, 18, 10.1016/0014-5793(87)80344-7 · DOI
- Bazan, 1989, A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor β-chain, Biochem. Biophys. Res. Commun., 164, 788, 10.1016/0006-291X(89)91528-3 · DOI
- Beuscher, 1988, Structure and function of membrane IL-1, Mol. Immunol., 25, 1189, 10.1016/0161-5890(88)90155-1 · DOI
- Boutin, 1988, Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family, Cell, 53, 69, 10.1016/0092-8674(88)90488-6 · DOI
- Cepko, 1984, Construction and applications of a highly transmissible murine retrovirus vector, Cell, 37, 1053, 10.1016/0092-8674(84)90440-9 · DOI
- D'Andrea, 1989, Expression cloning of the murine erythropoietin receptor, Cell, 57, 277, 10.1016/0092-8674(89)90965-3 · DOI
- D'Andrea, 1989, Erythropoietin receptor and interleukin-2 receptor β chain: a new receptor family, Cell, 58, 1023, 10.1016/0092-8674(89)90499-6 · DOI
- Fujita-Yamaguchi, 1983, Purification of insulin receptor with full binding activity, J. Biol. Chem., 258, 5045, 10.1016/S0021-9258(18)32535-3 · DOI
- Fukunaga, 1990, Expression cloning of a receptor for murine granulocyte colony-stimulating factor, Cell, 61, 341, 10.1016/0092-8674(90)90814-U · DOI
- Gearing, 1989, Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor, EMBO J, 8, 3667, 10.1002/j.1460-2075.1989.tb08541.x · DOI
- Goodwin, 1990, Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily, Cell, 60, 941, 10.1016/0092-8674(90)90342-C · DOI
- Green, 1986, PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor, J. Cell Biol., 102, 830, 10.1083/jcb.102.3.830 · DOI
- Hanks, 1988, The protein kinase family: conserved features and deduced phylogeny of the catalytic domains, Science, 241, 42, 10.1126/science.3291115 · DOI
- Hatakeyama, 1989, Interleukin-2 receptor β chain gene: generation of the three receptor forms by cloned human α and β chain cDNAs, Science, 244, 551, 10.1126/science.2785715 · DOI
- Hatakeyama, 1989, A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization, Cell, 59, 837, 10.1016/0092-8674(89)90607-7 · DOI
- Hempstead, 1989, Expression of functional nerve growth factor receptors after gene transfer, Science, 243, 373, 10.1126/science.2536190 · DOI
- Hirano, 1986, Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin, Nature, 324, 73, 10.1038/324073a0 · DOI · Paper page
- Hirata, 1989, Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies, J. Immunol., 143, 2900, 10.4049/jimmunol.143.9.2900 · DOI
- Horii, 1989, Involvement of interleukin-6 in mesangial proliferative glomerulonephritis, J. Immunol., 143, 3949, 10.4049/jimmunol.143.12.3949 · DOI
- Itoh, 1990, Cloning of an interleukin-3 receptor gene: a member of a distinct receptor gene family, Science, 247, 324, 10.1126/science.2404337 · DOI
- Kishimoto, 1989, The biology of interleukin-6, Blood, 74, 1, 10.1182/blood.V74.1.1.1 · DOI
- Kozak, 1987, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucl. Acids Res., 15, 8125, 10.1093/nar/15.20.8125 · DOI
- Leung, 1987, Growth hormone receptor and serum binding protein: purification, cloning and expression, Nature, 330, 537, 10.1038/330537a0 · DOI
- Lotz, 1988, BSF-2IL-6 is a costimulant for human thymocytes and T lymphocytes, J. Exp. Med., 167, 1253, 10.1084/jem.167.3.1253 · DOI
- Miyarua, 1988, Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells (M1), FEBS Lett., 234, 17, 10.1016/0014-5793(88)81293-6 · DOI
- Moos, 1988, Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin, Nature, 334, 701, 10.1038/334701a0 · DOI
- Mosley, 1989, The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms, Cell, 59, 335, 10.1016/0092-8674(89)90295-X · DOI
- Patthy, 1990, Homology of a domain of the growth hormone/prolactin receptor family with type III modules of fibronectin, Cell, 61, 13, 10.1016/0092-8674(90)90208-V · DOI
- Paul, 1989, Pleiotropy and redundancy: T cell-derived lymphokines in the immune response, Cell, 57, 521, 10.1016/0092-8674(89)90121-9 · DOI
- Ranscht, 1988, Sequence of contactin, a 130-kD glycoprotein concentrated in areas of interneuronal contact, defines a new member of the immunoglobulin supergene family in the nervous system, J. Cell Biol., 107, 1561, 10.1083/jcb.107.4.1561 · DOI
- Rettenmier, 1987, Synthesis of membrane-bound colonystimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes, Mol. Cell. Biol., 7, 2378
- Santos, 1989, Structural and functional properties of ras proteins, FASEB J., 3, 2151, 10.1096/fasebj.3.10.2666231 · DOI
- Satoh, 1988, Induction of neural differentiation in PC12 cells by B cell stimulatory factor 2/interleukin 6, Mol. Cell. Biol., 8, 3546
- Schreurs, 1989, A monoclonal antibody with IL-3-like activity blocks IL-3 binding and stimulates tyrosine phosphorylation, J. Immunol., 142, 819, 10.4049/jimmunol.142.3.819 · DOI
- Shabo, 1988, The myeloid blood cell differentlation-inducing protein MGI-2A is interleukin 6, Blood, 72, 2070, 10.1182/blood.V72.6.2070.2070 · DOI
- Sherr, 1985, The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1, Cell, 41, 665, 10.1016/S0092-8674(85)80047-7 · DOI
- Sims, 1988, cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily, Science, 241, 585, 10.1126/science.2969618 · DOI
- Skorstengaard, 1986, Complete primary structure of bovine plasma fibronectin, Eur. J. Biochem., 161, 441, 10.1111/j.1432-1033.1986.tb10464.x · DOI
- Sugita, 1990, Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain: its possible role in plasmacytomagenesis, J. Exp. Med., 171, 2001, 10.1084/jem.171.6.2001 · DOI
- Taga, 1987, Receptors for B cell stimulatory factor 2 (BSF-2): quantitation, specificity, distribution, and regulation of their expression, J. Exp. Med., 166, 967, 10.1084/jem.166.4.967 · DOI
- Taga, 1989, Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130, Cell, 58, 573, 10.1016/0092-8674(89)90438-8 · DOI · Paper page
- Van Damme, 1987, Identification of the human 26-kDa protein, interferon β2 (IFNβ2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor, J. Exp. Med., 165, 914, 10.1084/jem.165.3.914 · DOI
- von Heijne, 1986, A new method for predicting signal sequence cleavage sites, Nucl. Acids Res., 14, 4683, 10.1093/nar/14.11.4683 · DOI
- Yamasaki, 1988, Cloning and expression of the human interleukin-6 (BSF-2IFNβ2) receptor, Science, 241, 825, 10.1126/science.3136546 · DOI
- Yasukawa, 1987, Structure and expression of human B cell stimulatory factor 2 (BSF-2IL-6) gene, EMBO J., 6, 2939, 10.1002/j.1460-2075.1987.tb02598.x · DOI
- Yasukawa, 1990, Purification and characterization of soluble human IL-6 receptor expressed in CHO cells, J. Biochem., 108, 673, 10.1093/oxfordjournals.jbchem.a123261 · DOI
Cited by
Sorted by citations
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.
Vaisse, C., Halaas, J. L., Horvath, C. M., Darnell, J. E., Stoffel, M., & Friedman, J. M. (1996) · Nature Genetics · doi:10.1038/ng0996-95 · Cited by 1,086
Pro-inflammatory cytokines: The link between obesity and osteoarthritis
Wang, T., & He, C. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.002 · Cited by 1,034
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
Targeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Self-citationInterleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810
Muscle‐derived interleukin‐6: possible biological effects
Pedersen, B. K., Steensberg, A., & Schjerling, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0329c.xd · Cited by 599
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
Self-citationTargeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
The role of interleukin-6 signaling in nervous tissue
Rothaug, M., Becker-Pauly, C., & Rose-John, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.018 · Cited by 491
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
Ueda, T., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108255200 · Cited by 381
Historical overview of the interleukin-6 family cytokine
Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190347 · Cited by 360
Self-citationBaran, P., Hansen, S., Waetzig, G. H., Akbarzadeh, M., Lamertz, L., Huber, H. J., Ahmadian, M. R., Moll, J. M., & Scheller, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001163 · Cited by 235
Reeh, H., Rudolph, N., Billing, U., Christen, H., Streif, S., Bullinger, E., Schliemann-Bullinger, M., Findeisen, R., Schaper, F., Huber, H. J., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0356-0 · Cited by 180
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Kishimoto, T., & Kang, S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-023458 · Cited by 140
Self-citationZhang, P., Iwama, A., Datta, M. W., Darlington, G. J., Link, D. C., & Tenen, D. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1173 · Cited by 130
Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration
Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129
Molecular basis of the cell specificity of cytokine action
Ishihara, K., & Hirano, T. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00321-x · Cited by 122
Self-citationKwon, J. H., Moon, K. M., & Min, K.-W. (2020) · Healthcare · doi:10.3390/healthcare8040378 · Cited by 116
Lee, Y. E., Go, G.-Y., Koh, E.-Y., Yoon, H.-N., Seo, M., Hong, S.-M., Jeong, J. H., Kim, J.-C., Cho, D., Kim, T. S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006130 · Cited by 61
Wang, P., Feng, Y.-B., Wang, L., Li, Y., Fan, C., Song, Q., & Yu, S. Y. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.08.002 · Cited by 38
The Regenerative Activity of Interleukin-6
Galun, E., & Rose-John, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-308-4_4 · Cited by 34
Metadata
- Authors
- Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1990-12
- Volume
- 63
- Issue
- 6
- Pages
- 1149-1157
- ISSN
- 0092-8674
- Cited by
- 1,039
- References
- 0
- Language
- en
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review